Congenital rubella syndrome: Progress and future challenges

Expert Review of Vaccines

Volumn 8, Issue 3, 2009, Pages 323-331

  Morice, Ana ^a   Ulloa Gutierrez, Rolando ^b   Ávila Agüero, María L ^a  

^a Ministry of Health   (Costa Rica)

^b HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

Author keywords

Active surveillance; Central America; Congenital rubella syndrome; Costa Rica; Latin America; Pregnancy; Rubella; Vaccination strategies; Vaccine safety

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; RUBELLA VACCINE;

CONGENITAL CATARACT; CONGENITAL DEAFNESS; CONGENITAL HEART DISEASE; CONGENITAL RUBELLA SYNDROME; COSTA RICA; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MEASLES; MUMPS; PRIORITY JOURNAL; REVIEW; RUBELLA; ADOLESCENT; ADULT; CHILD; FEMALE; HEALTH CARE POLICY; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEWBORN; PREGNANCY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COSTA RICA; FEMALE; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; YOUNG ADULT;

EID: 63849320875     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.3.323     Document Type: Review

References (46)

1. Gregg NM. Congenital cataract following German measles in the mother. Aust NZ J. Ophthalmol. 3, 35-46 (1941). * First description of congenital rubella infection reporting cataract as a direct effect of rubella virus pathogenesis.
2. Banatvala JE, Brown DWG. Rubella. Lancet 363, 1127-1137 (2004). •• Expert review addressing rubella transmission, physiopathology, diagnosis and prevention of congenital rubella syndrome.
3. Grillner L, Forsgren M, Barr B, Boottiger M, Danielsson L, Verdier C. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand. J. Infect. Dis. 15, 321-325 (1983). •• Reports late effects of rubella infection, demonstrating that congenital defects, such as primarily deafness, occur after the first trimester of pregnancy.
4. Weller TH, Neva FA. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc. Soc. Exp. Biol. Med. 111, 225-230 (1962).
5. Bhate S, Kanvinde S, Mankar S, Phadke MA. Evaluation of efficacy of MMR vaccine in India. Conference Abstracts India (1994).
6. Centers for Disease Control and Prevention: nationwide campaign for vaccination of adults against rubella and measles Costa Rica 2001. MMWR Morb. Mort. Wkly Rep. 150, 976-979 (2001).
7. Preblud SR, Serdula MK, Frank JA, Branding-Bennett DA, Hinman AR. Rubella vaccination in the United States: a ten year review. Epidemiol. Rev. 2, 171-194 (1980).
8. Orenstein WA, Bart KJ, Hinman AR et al. The opportunity and obligation to eliminate rubella from the United States. JAMA 251, 1988-1994 (1984). * Reports the accelerated reduction in rubella incidence by a widespread use of rubella vaccine in the USA, reinforcing the importance to immunize high-risk groups, strengthen surveillance and outbreak control to achieve elimination.
9. Reef SE, Frey TK, Theall K et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 287, 464-472 (2002).
10. Reef SE, Plotkin S, Cordera JF et al. Preparing for elimination of congenital rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin. Infect. Dis. 31, 85-95 (2000).
11. Cheffins T, Chan A, Keane RJ, Haan EA, Hall R. The impact of rubella immunisation on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia. Br. J. Obstetr. Gynecol. 105, 998-1004 (1998).
12. Farber ME, Finkelstein SN. A cost-benefit analysis of a mandatory premarital rubella-antibody screening program. N. Engl. J. Med. 300, 856-859 (1979).
13. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J. Infect. Dis. 187(Suppl. 1), S146-S152 (2003). •• Comprehensive review of rubella-elimination strategies in the Americas, addressing the challenges to achieve rubella and congenital rubella syndrome elimination.
14. Kelly H, Worth L, Karapanagiotidis T, Riddell M. Interruption of rubella virus transmission in Australia may require vaccination of adults males: evidence from a Victorian sero-survey. Commun. Dis. Intel. 28, 69-73 (2004).
15. Villarejos VM, Arguedas-Gamboa JA, Vargas-Naar O, Cortés-Vargas MA. Study of the effectiveness and safety of rubella vaccine. Bol. Oficina Sanit. Panam. 70, 174-180 (1971).
16. Morice A, González L, Castillo- Solórzano C. Tendencias de la inmunidad a la rubéola en mujeres de edad fértil y pre-escolares en Costa Rica, 1969-1996. Acta. Pediatr. Costarr. 19, 13-18 (2005).
17. Morice A, Carvajal X, Leon M et al. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. J. Infect. Dis. 187(Suppl. 1), 158-163 (2003). ** Reports the success of an adult nationwide measles and rubella vaccination campaign in Costa Rica and the components of a National Plan of Action to eliminate rubella and measles.
18. Avila-Agüero ML, Morice A, Castillo-Solórzano C et al. Sindrome de rubéola congénita en Costa Rica: importancia de la vigilancia activa. An. Pediatr. (Barc.) 62, 43-47 (2005).
19. Jiménez G, Avila-Aguero ML, Morice A et al. Estimating the burden of congenital rubella syndrome in Costa Rica, 1996-2001. Pediatr. Infect. Dis. J. 26, 382-386 (2007). •• Presents an integrated approach to estimate congenital rubella syndrome incidence using combined sources of information, reinforcing the limitations of the passive surveillance system.
20. Badilla X, Morice A, Saenz E et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr. Infect. Dis. J. 26, 830-835 (2007). •• Prospective follow-up of inadvertently rubella vaccinated pregnant women during a national vaccination campaign, demonstrating no teratogenic effect of rubella vaccine.
21. Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am. J. Clin. Genetics 130, 52-54 (2004).
22. Centers for Disease Control and Prevention: Revised ACIP recommendation for avoiding pregnancy after reviewing a rubella-containing vaccine. MMWR Morb. Mort. Wkly Rep. 50, 1117 (2001).
23. Enders G. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccinations during pregnancy. Rev. Infect. Dis. 7(Suppl. 1), 5103-5107 (1985).
24. Centers for Disease Control and Prevention: Measles, mumps and rubella vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps. Recommendation of the Advisory Committee on Immunization Practices. MMWR Morb. Mort. Wkly Rep. 47(8), 1-57 (1998).
25. Anderson RM, May RM. Vacination against rubella and measles: quantitative investigations of different policies. J. Hygiene (Lond.), 90, 259-325 (1983).
26. Horstmann DM, Riordan JT, Ohtawara M, Niederman JC. A natural epidemic of rubella in a closed population: virological and epidemiological observations. Arch. Ges. Virusforsch. 16, 483-487 (1965).
27. Mellinger AK, Cragan JD, Atkinson WL et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr. Infect. Dis. J. 14, 573-578 (1995).
28. Greaves WL, Orenstein WA, Hinman AR, Nersesian WS. Clinical efficacy of rubella vaccine. Pediatr. Infect. Dis. 2, 284-286 (1983).
29. Balfour HH, Groth KE, Edelman CK. RA27/3 rubella vaccine. Am. J. Dis. Child. 134, 350-353 (1990).
30. Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15 year follow-up in Finland. Vaccine 18, 3106-3112 (2000). •• Long-term study that reinforces the evidence of the high effectiveness of the measles-mumps-rubella (MMR) vaccine and the long-term immunity induced by the rubella vaccination strategies.
31. Balfour HH, Groth KE, Edelman CK, Amren DP, Best JM, Banatvala JE. Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet 1, 1078-1080 (1981).
32. Plotkin SA, Orenstein WA. Rubella vaccine. In: Vaccines (4th Edition). Elsevier Inc., PA, USA 707-743 (2004).
33. Sterh-Green PA, Cochi SL, Preblud SR, Orenstein WA. Evidence against increasing rubella seronegativity among adolescent girls. Am. J. Public Health 80(1), 88 (1990).
34. Rafnar B. Rubella immunization of teenage girls in Iceland and follow-up after severe rubella epidemic. Bull. World Health Organ. 60, 141-146 (1980).
35. Gale JL, Detels R, Kim KSW, Beasley RP, Chen KP, Grayston T. The epidemiology of rubella on Taiwan. III. Family studies in cities of high and low attack rates. Int. J. Epidemiol. 1, 261-265 (1972).
36. Brody JA, Sever JL, Mc Alisiter R, Schiff GM, Cutting R. Rubella epidemic on St Paul Island in the Pribilofs, 1963. JAMA 191, 619-623 (1965).
37. CDC. Rubella and congenital rubella syndrome - United States 1984-1985. MMWR Morb. Mort. Wkly Rep. 35, 129-135 (1986).
38. Centers for Disease Control and Prevention. Update on Adult Immunization Recommendation Practices Advisory Committee (ACIP). MMWR Morb. Mort. Wkly Rep. 40(12), 1-52 (1991).
39. Reef SE, Cochi SL. The evidence for elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin. Infect. Dis. 43(Suppl. 3), S123-S125 (2006). •• Reports the approach to verify rubella and congenital rubella syndrome elimination in the USA and future challenges to maintain this goal.
40. Terada K. Rubella and congenital rubella syndrome in Japan: epidemiological problems. Jpn J. Infect. Dis. 56, 81-87 (2003).
41. Schtzmayr HG. Aspects of rubella infection in Brazil. Rev. Infect. Dis. 7(Suppl. 1), S53-S55 (1985).
42. Galazka A. Rubella in Europe. Epidemiol. Infect. 107, 43-54 (1991).
43. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunization in Greece: retrospective survey and systematic review. BMJ 319, 1462-1465 (1999).
44. Castillo-Solorzano, de Quadros CE. Accelerated rubella control and the prevention of congenital rubella syndrome. Rev. Panam. Salud Publica 11, 273-276 (2002).
45. Schuler WW, Reef S, Redd SC, Dykewicz CA. Changing epidemiology of congenital rubella syndrome in the United States. J. Infect. Dis. 178, 636-641 (1998).
46. Centers for Disease Control and Prevention. Progress toward elimination of rubella and congenital rubella syndrome - the Americas, 2003-2008. MMWR Morb. Mort. Wkly Rep. 57, 1176-1179 (2008).